Individuals with very high serum Lp(a) levels (>180 mg/dL or >430 nmol/L) are considered to have an equivalent lifetime ASCVD risk to those with untreated heterozygous familial hypercholesterolemia (HeFH) [125]. Here, LPA is linked to familial hypercholesterolemia.